BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
+9.49%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$142M
AUM Growth
+$142M
(-0.31%)
Cap. Flow
+$2.61M
Cap. Flow
% of AUM
1.84%
Top 10 Holdings %
Top 10 Hldgs %
76.61%
Holding
63
New
3
Increased
5
Reduced
7
Closed
6
Top Buys
| 1 |
Biodesix
BDSX
|
$6.14M |
| 2 |
Alphatec Holdings
ATEC
|
$988K |
| 3 |
Halozyme
HALO
|
$569K |
| 4 |
Prothena Corp
PRTA
|
$497K |
| 5 |
Elutia
ELUT
|
$413K |
Top Sells
| 1 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
$2.58M |
| 2 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$1.03M |
| 3 |
Ventyx Biosciences
VTYX
|
$754K |
| 4 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$726K |
| 5 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$598K |
Sector Composition
| 1 | Healthcare | 95.64% |
| 2 | Energy | 4.26% |
| 3 | Consumer Staples | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$96B
| $52.4M | 36.99% | 727,785 | – | – |
|
|
2
Biodesix
BDSX
$62.6M
| $11.6M | 8.19% | 5,039,633 +2,669,562 | +113% | +$6.14M |
|
3
Neurocrine Biosciences
NBIX
$13.8B
| $10.1M | 7.11% | 84,240 -1,000 | -1% | -$119K |
|
|
4
Prothena Corp
PRTA
$441M
| $7.66M | 5.41% | 127,195 +8,250 | +7% | +$497K |
|
|
5
Elutia
ELUT
$96.7M
| $6.44M | 4.55% | 1,515,184 +97,061 | +7% | +$413K |
|
6
QuidelOrtho
QDEL
$1.95B
| $5.25M | 3.71% | 61,306 | – | – |
|
7
Ovintiv
OVV
$10.8B
| $4.27M | 3.02% | 84,200 | – | – |
|
8
United Therapeutics
UTHR
$13.8B
| $4.17M | 2.95% | 15,000 | – | – |
|
9
Acadia Pharmaceuticals
ACAD
$4.38B
| $3.97M | 2.8% | 249,400 | – | – |
|
10
Phreesia
PHR
$1.88B
| $2.68M | 1.89% | 82,700 | – | – |
|
11
Harrow
HROW
$1.44B
| $2.66M | 1.88% | 180,000 | – | – |
|
|
ALBO
12
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $2.53M | 1.79% | 117,000 | – | – |
|
13
Masimo
MASI
$7.59B
| $2.26M | 1.6% | 15,280 | – | – |
|
|
INBX
14
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.74M | 1.23% | 70,448 | – | – |
|
15
Foghorn Therapeutics
FHTX
$286M
| $1.69M | 1.19% | 264,843 | – | – |
|
|
AXDX
16
DELISTED
Accelerate Diagnostics
AXDX
| $1.59M | 1.12% | 2,252,388 | – | – |
|
|
AVEO
17
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $1.5M | 1.06% | 100,000 -40,000 | -29% | -$598K |
|
18
Alkermes
ALKS
$4.78B
| $1.31M | 0.92% | 50,000 | – | – |
|
19
Cytokinetics
CYTK
$4.23B
| $1.15M | 0.81% | 25,000 | – | – |
|
|
20
Alphatec Holdings
ATEC
$2.35B
| $1.11M | 0.79% | 90,000 +80,000 | +800% | +$988K |
|
21
Corcept Therapeutics
CORT
$7.35B
| $1.02M | 0.72% | 50,000 | – | – |
|
22
Karyopharm Therapeutics
KPTI
$61.7M
| $991K | 0.7% | 291,332 +22,000 | +8% | +$74.8K |
|
|
ETRN
23
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $891K | 0.63% | 133,050 | – | – |
|
|
PXD
24
DELISTED
Pioneer Natural Resource Co.
PXD
| $868K | 0.61% | 3,800 | – | – |
|
25
DocGo
DCGO
$153M
| $778K | 0.55% | 110,000 | – | – |
|